Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:01:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:24.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:46.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:58:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Glossary display option added and QC-related metadata updated to show Last Update Submitted that Met QC Criteria and a revision footer with v3.4.0. The older QC wording (Last Update Submitted that met QC Criteria), No FEAR Act data, and Revision: v3.3.4 text were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:48:44.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4. No visible changes were made to study details or layout.
    Difference
    0.1%
    Check dated 2026-01-14T04:42:16.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.